1. Home
  2. AIP vs GNFT Comparison

AIP vs GNFT Comparison

Compare AIP & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIP
  • GNFT
  • Stock Information
  • Founded
  • AIP 2003
  • GNFT 1999
  • Country
  • AIP United States
  • GNFT France
  • Employees
  • AIP N/A
  • GNFT N/A
  • Industry
  • AIP Semiconductors
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AIP Technology
  • GNFT Health Care
  • Exchange
  • AIP Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • AIP 277.9M
  • GNFT 190.6M
  • IPO Year
  • AIP 2021
  • GNFT 2019
  • Fundamental
  • Price
  • AIP $11.89
  • GNFT $3.83
  • Analyst Decision
  • AIP Strong Buy
  • GNFT Strong Buy
  • Analyst Count
  • AIP 4
  • GNFT 1
  • Target Price
  • AIP $13.00
  • GNFT $13.00
  • AVG Volume (30 Days)
  • AIP 272.5K
  • GNFT 8.0K
  • Earning Date
  • AIP 02-18-2025
  • GNFT 09-19-2024
  • Dividend Yield
  • AIP N/A
  • GNFT N/A
  • EPS Growth
  • AIP N/A
  • GNFT N/A
  • EPS
  • AIP N/A
  • GNFT 0.47
  • Revenue
  • AIP $54,739,000.00
  • GNFT $86,225,222.00
  • Revenue This Year
  • AIP $8.13
  • GNFT $155.44
  • Revenue Next Year
  • AIP $19.08
  • GNFT N/A
  • P/E Ratio
  • AIP N/A
  • GNFT $7.65
  • Revenue Growth
  • AIP 4.53
  • GNFT 175.45
  • 52 Week Low
  • AIP $4.83
  • GNFT $3.31
  • 52 Week High
  • AIP $11.75
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • AIP 72.14
  • GNFT 41.47
  • Support Level
  • AIP $8.72
  • GNFT $3.58
  • Resistance Level
  • AIP $10.70
  • GNFT $3.81
  • Average True Range (ATR)
  • AIP 0.78
  • GNFT 0.14
  • MACD
  • AIP 0.11
  • GNFT 0.05
  • Stochastic Oscillator
  • AIP 99.69
  • GNFT 69.19

About AIP Arteris Inc.

Arteris Inc is a developer of on-chip interconnect fabric technology designed for a variety of devices and in the development and distribution of Network-on-Chip (NoC) interconnect intellectual property (IP). The company's technology is used in System-on-Chip (SoC) and provides software and services to automate SoC integration, enabling users to efficiently deploy NoC IP, and offer IP support, maintenance services, professional services, and training and on-site support services. The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: